Excellence in pharmaceutical supply chain performance is a key to creating “Reality from the Vision”. At the 2018 ISPE Annual Meeting & Expo, we will hear from two keynotes that will focus on the importance of innovation and management of our manufacturing and complex supply chains.
The End-to-End Supply Chain Track is going to help you create the “Reality” in “Reality from the Vision”. We have some exciting complementary sessions that will address many dimensions of the supply chain including:
The End-to-End Supply Chain Track includes sessions on the following topics:
Our session leaders and speakers are putting together a mix of practical experience case studies and forward looking innovative ideas for you to take away valuable knowledge to your company.
I look forward to meeting you in Philadelphia this November at the 2018 ISPE Annual Meeting & Expo – come and join us as we explore ways to achieve excellence.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...